Addiction

Study testing a combination therapy involving CBD in animal models shows promise in the hunt for treatment strategies to lower the dose of opioids for chronic pain.

In The Conversation, Drs. Habibeh Khoshbouei and Marcelo Febo discuss their new study paving the way to test immune-modulating medicines as a potential tool to break the cycle of meth addiction.

An MBI research team made a preclinical discovery paving the way to test immune-modulating medicines as a tool to break the cycle of meth addiction.

In The New York Times, Dr. Sara Jo Nixon discusses how alcohol impacts the body as you age.

Shelby Blaes is the latest MBI Rising Star, a video series highlighting up-and-coming neuroscience researchers at UF.

Dr. Scott Teitelbaum and the Association of American Medical Colleges colleagues urged lawmakers to pass the Opioid Workforce Act. It would fund 1,000 new addiction medicine residencies, easing the shortage of physicians who specialize in the treatment of substance use disorder.

In The Conversation, Dr. Sara Jo Nixon discusses holiday drinking, how much is “too much,” and offers tactics for responsible drinking during celebratory times.

Addiction research led by Drs. Caitlin Orsini and Marcelo Febo, was recently chosen as a Research Highlight in the journal eNeuro.

FRC medical director and MBI member Dr. Scott Teitelbaum's personal journey helps him lead others to recovery.

MBI researcher Doug Miller discusses why people with HIV are more likely to develop neurological diseases and addiction in The Conversation.